Profesorado y personal

El Dr. Hollander es profesor de psiquiatría y ciencias del comportamiento en el Albert Einstein College of Medicine y director del Programa de autismo y espectro obsesivo-compulsivo y del Programa de ansiedad y depresión en el Montefiore Medical Center y el Albert Einstein College of Medicine. Anteriormente se desempeñó como profesor y presidente de psiquiatría de la cátedra Esther y Joseph Klingenstein en la Mount Sinai School of Medicine y fue director del Seaver and NY Autism Center of Excellence en la ciudad de Nueva York. Antes de eso, se desempeñó como profesor asociado de psiquiatría clínica en el Columbia University College of Physicians and Surgeons en Nueva York.

El Dr. Hollander recibió su licenciatura en la Universidad Brandeis (1978) y su doctorado en Medicina en la Facultad de Medicina SUNY Downstate, Brooklyn (1982). Completó su internado en Medicina Interna en el Hospital Mt. Sinai (1983), su residencia y su puesto de jefe de residentes en Psiquiatría en la Facultad de Medicina Mt. Sinai (1986) y su beca de investigación del NIMH en la Facultad de Médicos y Cirujanos de la Universidad de Columbia (1988). Se desempeñó como Profesor Asociado de Psiquiatría Clínica en la Facultad de Médicos y Cirujanos de la Universidad de Columbia y como Profesor Esther y Joseph Klingenstein y Presidente de Psiquiatría en la Facultad de Medicina Mount Sinai.

Dr. Hollander has served as the principal investigator for a number of federal grants, including the NIH Greater New York Autism Center of Excellence; the NIMH Research Training Grant in Psychopharmacology and Outcomes Research; the DOD CBDV in ASD treatment study; and FDA funded multicenter treatment trials of pediatric body dysmorphic disorder, autism and Prader Willi Syndrome. He was the principal investigator of the autism Clinical Trials

Network, and Chair of the eight centers NIH STAART Autism Steering Committee. He is involved in research on the neuropharmacology, neuropsychiatry, functional imaging, and treatment of obsessive-compulsive disorder, impulsive-aggressive disorders, obsessive-compulsive-related disorders such as body dysmorphic disorder, pathological gambling; Prader Willi Syndrome, and autism. Dr. Hollander served as Chair of the DSM-V Research Planning Agenda for Obsessive Compulsive Behavior Spectrum Disorders, and member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Post-Traumatic and Dissociative Disorders Workgroup, and the Behavioral and Substance Addictions Workgroup.

El Dr. Hollander ha recibido un premio de desarrollo científico de investigación del Instituto Nacional de Salud Mental para investigar la psicobiología de los trastornos obsesivo-compulsivos y trastornos relacionados. Ha recibido subvenciones para medicamentos huérfanos de la Administración de Alimentos y Medicamentos para estudiar nuevos tratamientos para el trastorno dismórfico corporal, el autismo infantil/adolescente y el autismo en adultos, y una subvención del Instituto Nacional sobre Abuso de Drogas para un estudio sobre la neurobiología del juego patológico. Ha recibido varias subvenciones del Instituto Nacional de Salud Mental y del Instituto Nacional de Trastornos Neurológicos y Accidentes Cerebrovasculares para desarrollar tratamientos para el trastorno límite de la personalidad, el trastorno dismórfico corporal adolescente y el autismo; y una subvención del Departamento de Defensa para estudiar el CBDV en el trastorno del espectro autista. El Dr. Hollander ha recibido dos premios nacionales de investigación de la Asociación Estadounidense de Psiquiatría y un premio de investigador destacado de la Alianza Nacional para la Investigación en Esquizofrenia y Depresión.

Casara Jean Ferretti is a PhD candidate in the Clinical Psychology PhD Program with Health Emphasis at Ferkauf Graduate School of Psychology, Yeshiva University. She is a Project Director at the Autism and Obsessive Compulsive Spectrum Program at Albert Einstein College of Medicine, Montefiore Medical Center. Ms. Ferretti is clinically trained in CBT, and uses an integrative therapeutic approach in her clinical work, combining therapeutic tools from CBT, DBT, expressive therapies and other orientations to collaboratively treat children, adolescents, and adults. Ms. Ferretti has also worked with children, adolescents and adults with Autism Spectrum Disorder (ASD), and related disorders, in both clinical and research settings for the past 15 years. She is an established grant writer, and has multiple publications, book chapters and presentations on ASD and related fields, including as co-editor for the 2nd edition of 2nd Edition of APPI’s Textbook of Autism Spectrum Disorders. Ms. Ferretti is dedicated to providing integrative therapeutic care across the lifespan for individuals and families managing depression, anxiety, ADHD, ASD, and trauma, in addition to the intersection of mental health with familial, interpersonal, developmental, and environmental stressors. She is also focused on continuing her research for ASD and related disorders, investigating inflexible thinking, neurodivergent strengths and the importance of using a family systems approach.

Blerona Shaipi, M.D., graduated from the Medical University of Tirana, Albania in 2019, she made the bold decision to move to the United States, where she sought to further enrich her medical expertise and explore new opportunities in healthcare. She is a research fellow working with Dr. Eric Hollander at the Psychiatry Research Institute at Montefiore Einstein (PRIME). She is pursuing an internal medicine residency.

Hamaad Shehzad, M.D., graduated from St. George’s University School of Medicine in Grenada, W.I. in 2023. He is a research fellow working with Dr. Eric Hollander at the Psychiatry Research Institute at Montefiore Einstein (PRIME). He is pursuing a psychiatry residency and is interested in neurodevelopmental disorders, neurocognitive disorders, and psychosomatic medicine.

Philip Chu is a 3rd year medical student who is interested in psychiatry, and excited to contribute to the field. He is especially interested in learning about novel therapeutic approaches and enjoys keeping up to date with the latest research. Outside of research, he enjoys exploring New York City and finding the tastiest foods that won’t break your bank – Always happy to give recommendations!

Samia Taoulost is a 3rd year psychiatry resident at Montefiore Medical Center/Albert Einstein College of Medicine. Since October 2022, she has been supporting research projects at the Autism and Obsessive Compulsive Spectrum Program with Eric Hollander, MD. Her current research interests relate to investigating the therapeutic potential of nutritional interventions such as the ketogenic diet in neurodevelopmental disorders (NDD). After residency, Dr Taoulost plans to pursue child and adolescent psychiatry and hopes to continue partaking in research and advocacy activities to improve clinical outcomes and quality of care among patients with ASD and other NDD.

Lorenzo Casati, M.D., is a 3rd year resident in Psychiatry at "La Statale" University of Milan, Italy. He is attending a period as research trainee with Eric Hollander, MD, at Albert Einstein College of Medicine's PRIME center. He is proceeding in his studies on the effect of cannabinoids on obsessive-compulsive symptoms, which he investigated in his graduation paper. His field of interests also concerns Eating Disorders and Psychedelic Drugs.